Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Intraabdominal Infections

• P3 Study to Assess Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy for Adults With Infection Due to Carbapenem Resistant Enterobacterales
• EXTENDed Antibiotic Durations Compared to Standard Durations for Patients With Complicated Intra-abdominal Infection.
• Preventive Therapy of Postoperative Intra-abdominal Infection Based on Serum Lactate Changes
• Study to Assess Efficacy and Safety of PF-06947386 in Japanese Adult Patients With Complicated Intra-abdominal Infection
• Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese Adults
• Unfractioned Heparin for Treatment of Sepsis Caused by Abdominal Infection
• Effects of Dexmedetomidine vs Propofol in Patients With Intra-abdominal Sepsis
• Safety, Tolerability, and Pharmacokinetics of Sulopenem in Adolescents
• Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Cefiderocol in Hospitalized Pediatric Patients
• The Effect of Supraglottic and Oropharyngeal Decontamination on the Incidence of Ventilator-associated Pneumonia
• Ceftolozane/Tazobactam (MK-7625A) Plus Metronidazole Versus Meropenem for Participants With Complicated Intra-abdominal Infection (MK-7625A-015)
• Study Comparing Caspofungin to Placebo for the Treatment of ICU Intra-abdominal Candidiasis
• Sulopenem Versus Ertapenem for Complicated Intra-abdominal Infection (cIAI)
• LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Intra-abdominal Infection (cIAI)
• A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria.
• Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) in Japanese Participants With Complicated Intra-abdominal Infection or Complicated Urinary Tract Infection (MK-7655A-017)
• MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-Abdominal Infection (cIAI) (MK-7625A-035)
• Efficacy and Safety Study of Eravacycline Compared With Meropenem in Complicated Intra-abdominal Infections
• Study of Ceftolozane/Tazobactam (MK-7625A) in Combination With Metronidazole in Japanese Participants With Complicated Intra-abdominal Infection (MK-7625A-013)
• Determine the PK and Safety and Tolerability of ATM-AVI for the Treatment of cIAIs in Hospitalized Adults (REJUVENATE)
• Evaluation of Safety,Pharmacokinetics and Efficacy of CAZ-AVI With Metronidazole in Children Aged 3 Months to 18 Years Old With Complicated Intra-abdominal Infections (cIAIs).
• Effect Study of Tigecycline to Treat Severe Sepsis and Septic Shock
• Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults
• Antibiotic Safety (SCAMP)
• Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Complicated Intra-abdominal Infections
• Tygacil Drug Use Investigation
• A Study of the Safety and Effectiveness of Doripenem in Filipino Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections
• Compare Ceftazidime-Avibactam + Metronidazole vs Meropenem for Hospitalized Adults With Complicated Intra-Abd Infections
• A Study To Determine The Efficacy And Safety Of Tigecycline Compared With Imipenem/Cliastatin to Treat Complicated Intra-Abdominal Infection
• Ceftazidime-Avibactam for the Treatment of Infections Due to Ceftazidime Resistant Pathogens
• Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia
• Colistin and Rifampicin for MDR-Acinetobacter
• A Prospective Study of The Complement Depletion in Patients With Severe Abdominal Sepsis
• Autologous Fibrin Glues for Fistulas Closure
• Study of the Safety, Tolerability, and Efficacy of Relebactam (MK-7655) + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone to Treat Complicated Intra-Abdominal Infection [cIAI] (MK-7655-004)
• Compare Ceftazidime-Avibactam + Metronidazole Versus Meropenem for Hospitalized Adults With Complicated Intra-Abdominal Infections
• A Phase 3 Study Of Intravenous Metronidazole For Intrabdominal Infection
• Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Meropenem in Complicated Intraabdominal Infections
• Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
• GSK2251052 in the Treatment of Complicated Intra-abdominal Infections
• Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal Infections
• Safety and Efficacy Study to Compare IV CXA 101/Tazobactam and Metronidazole With Meropenem in Complicated Intraabdominal Infections
• A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
• Moxifloxacin i.v. in the Treatment of Complicated Intra-Abdominal Infection (cIAI)
• Study Evaluating The Safety And Effectiveness In Subjects With Tigecycline Treatment
• Moxifloxacin in Pediatric Subjects With Complicated Intra-abdominal Infection
• A Safety and Efficacy Study of Doripenem in Participants With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Urinary Tract Infections
• A Comparative Study of Ampicillin/Sulbactam Versus Moxifloxacin in the Treatment of Complicated Intra-abdominal Infections
• Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia
• Post-Authorization Study Evaluating Safety Of Tigecycline
• Dragon Study (the Safety and Efficacy for Treatment of Patients With Complicated Intra Abdominal Infections)
• Prospective Multicenter Doubleblind Randomized Study of NXL104/Ceftazidime + Metronidazole vs. Meropenem in Treatment of Complicated Intra-abdominal Infections
• Post-Marketing Study Of The Safety Of Tygacil (Tigecycline)
• T.E.A. Study Three Days Ertapenem Versus Three Days Ampicillin- Sulbactam
• Pharmacokinetic (PK) and Safety Study of Meropenem in Young Infants With Intra-abdominal Infections
• A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or Pneumonia
• Therapy of Complicated Intra-Abdominal Infections With Moxifloxacin or Ertapenem
• A Pharmacovigilance Evaluation And Assessment Of The Prescribing Practice For Tygacil In Usual Health Care Setting
• Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age
• Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cIAI
• A Study to Evaluate the Safety and Effectiveness of Ertapenem Versus Ceftriaxone/Metronidazole in the Treatment of Intra-abdominal Infections in Adults (0826-802)
• Ertapenem Sodium vs. Piperacillin/Tazobactam in the Treatment of Complicated Intra-Abdominal Infections (0826-037)
• A Comparative Phase IV Study Evaluating Efficacy & Safety Of Magnex(Cefoperazone-Sulbactam) In Intraabdominal Infections
• Effect of Rosuvastatin in Abdominal Sepsis
• Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI)
• Doripenem in the Treatment of Complicated Intra-Abdominal Infections
• Doripenem in the Treatment of Complicated Intra-Abdominal Infections
• Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection
• A Study to Evaluate Ertapenem Versus It's Comparator in the Treatment of Complicated Intra-abdominal Infections in Adults (0826-050)(COMPLETED)
• Study Comparing Tigecycline and Imipenem/Cilastatin in Chinese Subjects With Complicated Intra-Abdominal Infections
• An Investigational Agent for the Treatment of Complicated Intra-Abdominal Infections or Acute Pelvic Infections (0826-038)
• Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized Subjects
• Study Evaluating Zosyn in Hospitalized Patients With Intra-abdominal Infection